LLiiffee SScciieennccee SSeemmiinnaarr SSeerriieess
Coordinator: Dr. Jana Jass Tel: 019-303943, e-mail: [email protected]
WWeeddnneessddaayy��NNoovveemmbbeerr��1177,,��22001100��1122..1155��1133..0000��iinn��HHöörrssaall��PPrriissmmaa��11��
��ÖÖrreebbrroo��UUnniivveerrssiittyy����
AAllll��WWeellccoommee��//��VVäällkkoommnnaa����
IIss HHoommoo eeccoonnoommiiccuuss aa MMoonnkkeeyy??
Prof Lars Hultkrantz Swedish Business School,
Örebro University
Thursday May 3, 2018 13.15 - 14.00 in Hörsal B (Bilbergska)
Örebro University
IIImmmmmmuuunnneee cccyyytttooolllyyytttiiiccc aaaccctttiiivvviiitttyyy iiinnn cccaaannnccceeerrr ––– ssspppoootttllliiiggghhhttt ooonnn
cccooolllooorrreeeccctttaaalll cccaaannnccceeerrr
Assis. Prof. Apostolos Zaravinos
Department of Life Sciences European University Cyprus
Host: Jana Jass Dr. Zaravinos's research is focus is on the advanced understanding of carcinogenesis through the investigation of immune cytolytic activity. Immune cytolytic activity is determined by the expression of granzyme A and perforin 1, both being secreted by effector cytotoxic T-‐cells (CTL) and natural killer (NK) cells. High levels of these substances are exhibited upon CD8+ T-‐cell activation and during a productive clinical response against immune checkpoint blockade therapies.
